USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AMO Groningen B.V.

USPTO PatentsView assignee record — 116 granted patents across 17 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

116
Total patents granted
17
CPC technology areas
14.3
Avg claims per patent
+42%
5-year filing velocity

Portfolio overview

AMO Groningen B.V. has been granted 116 US utility patents between 2015 and 2025, placing AMO Groningen B.V. at rank #3,218 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, AMO Groningen B.V. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 50.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 68 grants, compared with 48 in the 2015–2019 window — a +42% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. AMO Groningen B.V.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark AMO Groningen B.V. against peers pursuing similar technology classes.

How does AMO compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows AMO holds 116 patents — placing it at rank #3,218 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

05101520 20152016201720182019202020212022202320242025 12
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
AMO Groningen B.V. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 5.2%
2016 5 4.3%
2017 11 9.5%
2018 15 12.9%
2019 11 9.5%
2020 7 6.0%
2021 8 6.9%
2022 15 12.9%
2023 15 12.9%
2024 11 9.5%
2025 12 10.3%

Which technologies does AMO Groningen B.V. patent most?

Top 15 of 17 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#3,218

Across all tracked assignees

Innovation Score

50.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does AMO Groningen B.V. hold?
AMO Groningen B.V. holds 116 US granted patents filed between 2015 and 2025, spanning 17 technology areas.
What is AMO Groningen B.V.'s Innovation Score?
AMO Groningen B.V. has an Innovation Score of 50.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does AMO Groningen B.V. focus on?
AMO Groningen B.V.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 109 patents. The company has filed patents in 17 CPC subclasses total.
Is AMO Groningen B.V.'s patent filing rate increasing or decreasing?
AMO Groningen B.V.'s recent filing velocity is +42% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for AMO Groningen B.V.'s patents?
AMO Groningen B.V.'s patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the AMO Groningen B.V. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope